Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Launches First Generic Zoloft

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer counters with “authorized” generic through its Greenstone division.
Advertisement

Related Content

Generic Drug Sales Grew 22 Percent In 2006 Driven By Unbranded Zocor, Plavix
Teva Employs Brand-Like Patent Litigation To Retain Generic Zoloft Exclusivity
Lexapro Scripts Hold Up Against Competition From Generic Zoloft
Supreme Court Denial Of Apotex Cert Against Pfizer Could Negatively Impact Generic Firms
Zoloft Erosion Outpaces Other Recent Generic Launches
Epix’ Antidepressant Needs Big Pharma Partner For Launch
Merck’s Discounted Zocor Has Had “Negligible Impact,” Teva Says
FDA Approves Teva’s Generic Zoloft
FDA Approves Teva’s Generic Zoloft
Pfizer Prepares For Zoloft Authorized Generic Entry Following Teva’s Launch

Topics

Advertisement
UsernamePublicRestriction

Register

PS064668

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel